Teva Pharmaceuticals Presents 4th Interim Analysis Of PEARL Migraine Prevention Study At EAN Congress; New Sub-Analysis Highlights Potential Negative Impact Of Treatment Pauses On Patient Outcomes

4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in HelsinkiNew sub-analysis of PEARL data highlights potential neg

BenzingaJun 28 11:31 ET

Express News | 'The U.S. Readies to Evacuate Americans From Lebanon If Fighting Between Israel and Hezbollah Intensifies' - NBC News

BenzingaJun 27 16:28 ET

Teva Pharmaceutical Indus Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/27/2024 39.56% Jefferies $19 → $23 Maintains Buy 06/05/2024 27.43% Barclays $20 → $21 Maintains Overwei

BenzingaJun 27 11:36 ET

Gain Rotation Out of Semis Is Feeding Into Other Parts of the Market - Argus

Seeking AlphaJun 26 12:31 ET

Teva Pharmaceutical Industries Launches Authorized Generic Of Victoza In United States

Generic Victoza is the first-ever generic GLP-1 and supports increased demand for this category of therapies in the U.S. market.This launch adds to Teva's continued commitment to its complex generic m

BenzingaJun 24 09:50 ET

Palestine Red Crescent Says 18 Palestinians Killed, 35 Injured In Israeli Attack On Displaced People's Tents In Rafah's Mawasi

Palestine Red Crescent Says 18 Palestinians Killed, 35 Injured In Israeli Attack On Displaced People's Tents In Rafah's Mawasi

BenzingaJun 21 11:09 ET